Ohio Governor and Chief Medical Advisor Asked About Speeding Up Delivery of Therapies to COVID Patients

The Ohio Star reported that Ohio Governor Mike DeWine called a special press conference on Monday, November 23 alongside the Ohio Hospital Association leaders to address the state’s COVID hospitalization rise.

As reported, during the briefing doctors who lead each of Ohio’s three zones (the state is segmented into three areas) disclosed staffing shortages due to COVID quarantine orders, which had further depleted caregiving capacity already run thin by upticks in COVID hospital cases around the state.

The Star has received inquiries from readers describing their situations.  One woman told the story of her husband who was alerted that he had been exposed to COVID and within days began exhibiting symptoms. When he called his doctor seeking preventative therapies, he was denied.  The man was later admitted to a hospital for days, where he received therapeutic treatments that aided his recovery.

Consequently, The Star took the opportunity during Governor DeWine’s twice-weekly COVID presser on Tuesday to ask the following question:

Read More

Facebook to Ohio Conservative: You Can’t Do That Here

Ohioan Vanessa Treft is a political grassroots consultant who has worked in multiple states – Treft is a Trump supporter.

Treft has been outspoken about Ohio’s COVID response – from her grandmother’s inability to receive hydroxychloroquine immediately following a COVID diagnosis, to her calling out Ohio Republican Governor Mike DeWine’s refusal to adequately address senior living situations.

Read More

Minnesota Lifts Statewide Ban on Hydroxychloroquine

Governor Walz lifted the restrictions on access to hydroxychloroquine, a drug that has been in use for decades to treat a wide variety of illnesses – including SARS-type infections – that some say may be an effective therapeutic for COVID-19. The removal of limitations on the drug were outlined in Walz’s latest executive order issued last week.

Walz did not give an explanation for the reversal of his order on the drug.

Read More

Dr. Simone Gold of America’s Frontline Doctors Responds to Twitter’s Censorship of Her Account

Dr. Simone Gold, a board-certified emergency physician and the founder of America’s Frontline Doctors, has responded to Twitter’s removal of her tweet about treatments for COVID-19 and locking her out of her account.

In her response, Dr. Gold – who also graduated from Stanford Law School after completing her medical degree – called out her temporary Twitter ban, calling the action “another classic case of tech censorship against anyone who speaks out against the media narrative.”

Read More

Ohio Regulators Ban, Then Un-Ban ‘Controversial’ COVID Drug

The Ohio Pharmacy Board (OPB) implemented – then quickly reversed – a ban on the use of hydroxychloroquine Thursday. The move followed a revocation of the emergency use authorization by the FDA earlier this month. Previously, President Trump said the decades-old drug could be used as a preventative treatment for a deadly symptom of the disease that causes the lungs to lose function.

As of today, a new rule is set to go into effect regarding the drug, hydroxychloroquine. The OPB published a memo on the rule change stating “in general, the rule prohibits the use of hydroxychloroquine and chloroquine for the treatment or prevention of COVID-19.”

Read More

STUDY: Anti-Malarial Drug Used to Treat Lupus Helped COVID-19 Patients Survive, Despite Media Claims

An anti-malarial drug that President Donald Trump hyped as a potential therapy for the coronavirus helped some patients survive the disease while in the hospital, according to research published Wednesday.

Some of those who received hydroxychloroquine before acute symptoms began were much less likely to die from the virus, according to researchers at Henry Ford Health System in Michigan. Their findings come after other studies determined that the experimental drug provided little or no benefit to people struggling with the coronavirus, or COVID-19.

Read More

FDA Revokes Emergency Use of Malaria Drugs to Treat Coronavirus, Cites ‘Potential Risks’

U.S. regulators on Monday revoked emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19 amid growing evidence they don’t work and could cause deadly side effects.

The Food and Drug Administration said the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus. Citing reports of heart complications, the FDA said the drugs’ unproven benefits “do not outweigh the known and potential risks.”

Read More

Leading Study on Malaria Drug for Coronavirus Retracted: ‘Based on This Development, We Can No Longer Vouch for the Veracity of the Primary Data Source’

Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists.

Thursday’s retraction in the journal Lancet involved a May 22 report on hydroxychloroquine and chloroquine, drugs long used for preventing or treating malaria but whose safety and effectiveness for COVID-19 are unknown.

Read More

Money and Politics Behind Anti-Hydroxychloroquine Bias, New Report Suggests

Remdesivir, an antiviral medication that was developed by the biopharmaceutical company Gilead Sciences, has been widely touted as the most promising drug to treat COVID-19, even though – so far – the new and expensive drug does not seem to be terribly effective at fighting the disease.

The anti-malaria drug hydroxychloroquine, on the other hand, is cheap, has been used safely for decades, and has shown great promise as a weapon in the fight against the coronavirus – yet after President Trump mentioned it as a promising potential treatment for the disease, the media immediately blasted him for touting an “unproven” and potentially unsafe drug.

Read More

Commentary: Progressive Woke Orthodoxy Obscures the Truth About the Virus

Americans are acquainted with predictable but ultimately failed progressive efforts to suppress free expression by preemptive invective and politically correct finger-pointing.

To believe that U.S. Supreme Court Justice Brett Kavanaugh’s accusers revealed too many contradictions, too many lacunae, too many episodes of timely amnesia, and too many unsubstantiated accusations in their testimonies was chauvinistically to attack/smear/silence all women’s voices – at least until the same sort of memory-repressed accusations focused on handsy Joe Biden.

To express skepticism that current global temperatures are uniformly rising almost entirely due to human carbon emissions, that this state of affairs poses catastrophic dangers that may end civilization as we know it, and that this emergency can only be addressed by the radical restructuring of global economies is to be rendered a denialist, a crank, a fool.

But these parameters of censorship have a logic and predictability, given their race/class/gender/environmental orthodoxy.

Read More

Michigan Dem Says Chloroquine Saved Her Life, Thanks Trump for ‘Making It a Priority’

A Democrat state representative from Detroit, Michigan, who has been battling the coronavirus for weeks, is crediting hydroxychloroquine for saving her life, the Detroit Free Press reported on Monday.  State Rep. Karen Whitset thanked President Trump  – even as the corporate media continued to criticize him for touting an “unproven” drug—because she would not have asked for it unless he had brought it up.

Read More

Trump Pushes Lupus-Coronavirus Study, But the Evidence Is Mixed

by Chuck Ross   President Donald Trump again touted the drug hydroxychloroquine Saturday, citing an unspecified study showing that lupus patients are fighting off coronavirus infections because they take the drug hydroxychloroquine. Trump has come under fire from some health experts and journalists for hyping the hydroxychloroquine as a potential…

Read More

Senator Marsha Blackburn Urges FDA to Respond to Critical Drug Shortages

Senator Marsha Blackburn

U.S. Republican Sen. Marsha Blackburn of Tennessee this week urged U.S. Food and Drug Administration officials to address shortages of drugs used to treat patients with lupus.

Hydroxychloroquine and chloroquine, used to treat autoimmune diseases like lupus, are currently used to treat COVID-19.

“We should not be facing a choice between treating lupus and COVID-19,” Blackburn said in a statement.

Read More